IL232916A - 6-diplouromethyl-6,5-dihydro-h2 [4,1] oxazin-3-amine - Google Patents

6-diplouromethyl-6,5-dihydro-h2 [4,1] oxazin-3-amine

Info

Publication number
IL232916A
IL232916A IL232916A IL23291614A IL232916A IL 232916 A IL232916 A IL 232916A IL 232916 A IL232916 A IL 232916A IL 23291614 A IL23291614 A IL 23291614A IL 232916 A IL232916 A IL 232916A
Authority
IL
Israel
Prior art keywords
oxazin
difluoromethyl
dihydro
amine derivatives
amine
Prior art date
Application number
IL232916A
Other languages
English (en)
Hebrew (he)
Other versions
IL232916A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL232916A0 publication Critical patent/IL232916A0/en
Publication of IL232916A publication Critical patent/IL232916A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL232916A 2011-12-05 2014-06-02 6-diplouromethyl-6,5-dihydro-h2 [4,1] oxazin-3-amine IL232916A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11191997 2011-12-05
PCT/EP2012/074351 WO2013083557A1 (en) 2011-12-05 2012-12-04 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives

Publications (2)

Publication Number Publication Date
IL232916A0 IL232916A0 (en) 2014-08-03
IL232916A true IL232916A (en) 2016-07-31

Family

ID=47278317

Family Applications (1)

Application Number Title Priority Date Filing Date
IL232916A IL232916A (en) 2011-12-05 2014-06-02 6-diplouromethyl-6,5-dihydro-h2 [4,1] oxazin-3-amine

Country Status (18)

Country Link
US (1) US20140343048A1 (enExample)
EP (1) EP2788346B1 (enExample)
JP (1) JP6169095B2 (enExample)
KR (1) KR102060379B1 (enExample)
CN (1) CN103974951B (enExample)
AU (1) AU2012347397B2 (enExample)
BR (1) BR112014013310A2 (enExample)
CA (1) CA2852366C (enExample)
EA (1) EA023909B1 (enExample)
ES (1) ES2558604T3 (enExample)
IL (1) IL232916A (enExample)
MX (1) MX357384B (enExample)
MY (1) MY165209A (enExample)
PH (1) PH12014501235A1 (enExample)
SG (1) SG11201402734XA (enExample)
UA (1) UA111749C2 (enExample)
WO (1) WO2013083557A1 (enExample)
ZA (1) ZA201404074B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009258496B8 (en) 2008-06-13 2014-06-26 Shionogi & Co., Ltd. Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity
UA110467C2 (uk) 2009-12-11 2016-01-12 Шионогі Енд Ко., Лтд. Похідні оксазину
PH12012502377A1 (en) 2010-06-09 2014-10-14 Janssen Pharmaceutica Nv 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
NZ610948A (en) 2010-12-22 2014-06-27 Janssen Pharmaceutica Nv 5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (bace)
BR112013022917A2 (pt) 2011-03-09 2016-12-06 Janssen Pharmaceutica Nv derivados 3,4-dihidro-pirrolo[1,2-a]pirazino-1-ilamina úteis como inibidores de beta-secretase (bace)
JP5989130B2 (ja) * 2011-12-06 2016-09-07 ヤンセン ファーマシューティカ エヌ.ベー. 5−(3−アミノフェニル)−5−アルキル−5,6−ジヒドロ−2h−[1,4]オキサジン−3−アミン誘導体
EP2912035A4 (en) 2012-10-24 2016-06-15 Shionogi & Co DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY
JP6325092B2 (ja) 2013-06-12 2018-05-16 ヤンセン ファーマシューティカ エヌ.ベー. βーセクレターゼ(BACE)の阻害剤としての4−アミノ−6−フェニル−5,6−ジヒドロイミダゾ[1,5−A]ピラジン誘導体
KR102243133B1 (ko) 2013-06-12 2021-04-22 얀센 파마슈티카 엔.브이. 베타-세크레타제(bace) 저해제로서의 4-아미노-6-페닐-6,7-디하이드로[1,2,3]트리아졸로[1,5-a]피라진 유도체
KR102243135B1 (ko) 2013-06-12 2021-04-22 얀센 파마슈티카 엔.브이. 베타-세크레타제(bace) 저해제로서의 4-아미노-6-페닐-5,6-디하이드로이미다조[1,5-a]피라진-3(2h)-온 유도체
EP3233834B1 (en) 2014-12-18 2019-11-13 Janssen Pharmaceutica NV 2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2h-pyrrol-5-amine derivatives useful as inhibitors of beta-secretase
WO2021154599A1 (en) * 2020-01-27 2021-08-05 Silcotek Corp. Biopharmaceutical manufacturing process and product

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY32799A (es) 2009-07-24 2011-02-28 Novartis Ag Derivados de oxazina y su uso en el tratamiento de trastornos neurológicos
US8188079B2 (en) * 2009-08-19 2012-05-29 Hoffman-La Roche Inc. 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
UA103272C2 (uk) * 2009-12-11 2013-09-25 Ф. Хоффманн-Ля Рош Аг 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2
PH12012502377A1 (en) * 2010-06-09 2014-10-14 Janssen Pharmaceutica Nv 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
MX2013008111A (es) * 2011-01-12 2013-10-30 Novartis Ag Derivados de oxazina y su uso en el tratamiento de transtornos neurologicos.
CN103608345A (zh) * 2011-04-26 2014-02-26 盐野义制药株式会社 噁嗪衍生物和含有该噁嗪衍生物的bace1抑制剂
JP5989130B2 (ja) * 2011-12-06 2016-09-07 ヤンセン ファーマシューティカ エヌ.ベー. 5−(3−アミノフェニル)−5−アルキル−5,6−ジヒドロ−2h−[1,4]オキサジン−3−アミン誘導体

Also Published As

Publication number Publication date
UA111749C2 (uk) 2016-06-10
US20140343048A1 (en) 2014-11-20
WO2013083557A1 (en) 2013-06-13
MY165209A (en) 2018-03-05
ES2558604T3 (es) 2016-02-05
EA201491116A1 (ru) 2014-12-30
JP6169095B2 (ja) 2017-07-26
KR102060379B1 (ko) 2019-12-30
IL232916A0 (en) 2014-08-03
SG11201402734XA (en) 2014-06-27
JP2015500223A (ja) 2015-01-05
KR20140107209A (ko) 2014-09-04
HK1198586A1 (zh) 2015-04-30
CN103974951B (zh) 2016-04-13
MX357384B (es) 2018-07-06
NZ626662A (en) 2015-05-29
PH12014501235B1 (en) 2014-09-08
AU2012347397B2 (en) 2016-09-22
CA2852366A1 (en) 2013-06-13
ZA201404074B (en) 2016-10-26
BR112014013310A2 (pt) 2017-06-13
EP2788346A1 (en) 2014-10-15
AU2012347397A1 (en) 2014-04-24
EP2788346B1 (en) 2015-10-28
CN103974951A (zh) 2014-08-06
CA2852366C (en) 2020-02-18
PH12014501235A1 (en) 2014-09-08
EA023909B1 (ru) 2016-07-29
MX2014006689A (es) 2014-09-04

Similar Documents

Publication Publication Date Title
ZA201205788B (en) 1,2,4-triazine-4-amine derivatives
SI2694508T1 (sl) Soli substituiranega 2,3-dihidroimidazo(1,2-C)kinazolina
ZA201401884B (en) New dihydroquinoline-2-one derivatives
SG10201601802YA (en) Dispiropyrrolidine derivatives
ZA201404074B (en) 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives
GB201107176D0 (en) Pyrrolnitrin derivatives
GB201216143D0 (en) .
EP2699091A4 (en) 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS
SG11201401937YA (en) New aryl-quinoline derivatives
IL247640A0 (en) History of heteroaryl piperidine
GB201203412D0 (en) .
IL232917A0 (en) History of 5-(3-aminophenyl)-5-alkyl-6,5-dihydro-2h[4,1]oxazin-3-amine
ZA201306229B (en) Substituted 4-aryl-n-phenyl-1,3,5-triazin-2- amines
EP2675773A4 (en) PROCESS FOR THE PREPARATION OF CIS-1-CHLORO-3,3,3-TRIFLUOROPROPENE
LT2771327T (lt) Nauji pirazino dariniai
MY165626A (en) 1,2,4,-triazolone derivative
GB201203063D0 (en) .
IL233001A0 (en) New iso-ergoline histories
SI2766342T1 (sl) Derivati fenil-gvanidina
ZA201308049B (en) 3-ureidoisoquinolin-8-yl derivatives
IL232630A0 (en) A method for the preparation of 6,2-difluoroacetophenones
ZA201209319B (en) Cyclopropyl-indole derivatives
GB201203786D0 (en) .
GB201204535D0 (en) .
GB201120548D0 (en) .

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed